{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Treatment of WT mice with topical ocular 0 . 1 % dexamethasone led to elevation of intraocular pressure ( IOP ) , functional and structural loss of retinal ganglion cells , and axonal degeneration , resembling glucocorticoid - induced glaucoma in human patients .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Glaucoma (glucocorticoid-induced) |\n| Functional loss of retinal ganglion cells |\n| Structural loss of retinal ganglion cells |\n| Axonal degeneration |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Glaucoma (glucocorticoid-induced) |\n| Functional loss of retinal ganglion cells |\n| Structural loss of retinal ganglion cells |\n| Axonal degeneration (axonal degeneration) |\n\nNote: In this case, all entities in the paragraph refer to diseases or conditions affecting the eye, so there are no entities that do not clearly refer to diseases that need to be removed."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Treatment of WT mice with topical ocular 0 . 1 % dexamethasone led to elevation of intraocular pressure ( IOP ) , functional and structural loss of retinal ganglion cells , and axonal degeneration , resembling glucocorticoid - induced glaucoma in human patients .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| 0.1 % dexamethasone |\n\nIn this paragraph, the only chemical entity mentioned is the concentration of dexamethasone (0.1 %)."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| 0.1 % dexamethasone |\n\nIn the paragraph, the only clearly mentioned chemical entity is the concentration of dexamethasone (0.1 %). The other entities, such as WT mice, intraocular pressure (IOP), functional and structural loss of retinal ganglion cells, axonal degeneration, and glucocorticoid-induced glaucoma, do not refer to specific chemicals."}
  ]
}